U.S. Patent granted for Xenon MRI | 16-Apr-2024 | 07:00 | RNS |
Exercise of Warrants, Issue of Equity and TVR | 14-Mar-2024 | 07:00 | RNS |
Holding(s) in Company | 12-Mar-2024 | 15:59 | RNS |
2024 Polarean Strategy Update | 29-Feb-2024 | 07:00 | RNS |
Block Listing Six Monthly Return | 26-Jan-2024 | 07:00 | RNS |
Comment re: share purchase | 15-Jan-2024 | 07:00 | RNS |
Holding(s) in Company | 12-Jan-2024 | 17:00 | RNS |
Holding(s) in Company | 12-Jan-2024 | 17:00 | RNS |
Company Update | 07-Dec-2023 | 07:00 | RNS |
Holding(s) in Company | 27-Nov-2023 | 07:00 | RNS |
Directorate Change | 27-Sep-2023 | 13:59 | RNS |
Partnership with VIDA | 08-Sep-2023 | 07:00 | RNS |
Half-year Report | 07-Sep-2023 | 16:54 | RNS |
Half-year Report | 07-Sep-2023 | 07:00 | RNS |
Reimbursement code price range for XENOVIEW | 05-Sep-2023 | 11:51 | RNS |
Currency | UK Pounds |
Share Price | 3.80p |
Change Today | -0.100p |
% Change | -2.56 % |
52 Week High | 30.75 |
52 Week Low | 3.72 |
Volume | 161,416 |
Shares Issued | 215.85m |
Market Cap | £8.20m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
14:57 | 500 @ 3.90p |
14:23 | 1,424 @ 3.84p |
13:05 | 821 @ 3.84p |
12:17 | 1,212 @ 3.84p |
10:23 | 6,932 @ 3.84p |
CFO | Charles Osborne |
CEO | Christopher von Jako |
You are here: research